Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 19001-19050 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03703778
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)
N/A
Active, not recruiting
300 participants
Started: May 22, 2016 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT02628405
R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: May 20, 2016 · Completed: Dec 20, 2025
8 conditions
2 sponsors
12 locations
NCT02676739
Adderall XR and Cognitive Impairment in MS
PHASE2/PHASE3
Active, not recruiting
180 participants
Started: May 20, 2016 · Completed: Dec 31, 2024
1 condition
1 sponsor
3 locations
NCT02750358
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
PHASE2
Active, not recruiting
50 participants
Started: May 19, 2016 · Completed: May 31, 2026
3 conditions
3 sponsors
12 locations
NCT02339922
Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma
PHASE2
Active, not recruiting
33 participants
Started: May 19, 2016 · Completed: Jan 6, 2031
9 conditions
2 sponsors
1 location
NCT02568566
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants
PHASE2
Active, not recruiting
201 participants
Started: May 19, 2016 · Completed: Jan 10, 2026
1 condition
1 sponsor
2 locations
NCT02711553
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
PHASE2
Active, not recruiting
309 participants
Started: May 19, 2016 · Completed: Dec 31, 2026
3 conditions
1 sponsor
82 locations
NCT02780310
Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma
PHASE2
Active, not recruiting
33 participants
Started: May 19, 2016 · Completed: May 31, 2026
1 condition
2 sponsors
6 locations
NCT02617849
Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma
PHASE2
Active, not recruiting
30 participants
Started: May 19, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT02734134
One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection
NA
Active, not recruiting
343 participants
Started: May 18, 2016 · Completed: Jan 31, 2026
1 condition
14 sponsors
5 locations
NCT02682641
Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL
PHASE2
Active, not recruiting
50 participants
Started: May 18, 2016 · Completed: Dec 31, 2024
1 condition
2 sponsors
15 locations
NCT02703623
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE2
Active, not recruiting
196 participants
Started: May 18, 2016 · Completed: Mar 31, 2026
5 conditions
2 sponsors
3 locations
NCT02758717
Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma
PHASE2
Active, not recruiting
46 participants
Started: May 13, 2016 · Completed: Sep 13, 2025
11 conditions
2 sponsors
9 locations
NCT03578484
Breast Aesthetics by Three Dimensional Measures
N/A
Active, not recruiting
32 participants
Started: May 13, 2016 · Completed: Mar 20, 2032
1 condition
8 sponsors
2 locations
NCT02496663
Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
PHASE1
Active, not recruiting
138 participants
Started: May 11, 2016 · Completed: Jun 30, 2027
3 conditions
1 sponsor
15 locations
NCT02668770
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
PHASE1
Active, not recruiting
28 participants
Started: May 11, 2016 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03271892
Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer
N/A
Active, not recruiting
200 participants
Started: May 11, 2016 · Completed: Dec 31, 2031
1 condition
4 sponsors
1 location
NCT02466971
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
PHASE3
Active, not recruiting
450 participants
Started: May 10, 2016 · Completed: Jul 14, 2026
21 conditions
2 sponsors
382 locations
NCT02398773
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
PHASE2
Active, not recruiting
99 participants
Started: May 4, 2016 · Completed: Dec 31, 2025
4 conditions
1 sponsor
25 locations
NCT02726386
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease
PHASE2
Active, not recruiting
214 participants
Started: May 4, 2016 · Completed: Feb 28, 2027
1 condition
1 sponsor
57 locations
NCT02502266
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
PHASE2/PHASE3
Active, not recruiting
582 participants
Started: May 3, 2016 · Completed: Jul 16, 2026
15 conditions
3 sponsors
398 locations
NCT02650401
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
PHASE1/PHASE2
Active, not recruiting
69 participants
Started: May 3, 2016 · Completed: Jun 30, 2026
2 conditions
1 sponsor
27 locations
NCT02452008
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
PHASE2
Active, not recruiting
60 participants
Started: May 3, 2016 · Completed: May 31, 2026
1 condition
3 sponsors
4 locations
NCT03088098
Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI
NA
Active, not recruiting
80 participants
Started: May 2, 2016 · Completed: Sep 14, 2024
2 conditions
2 sponsors
1 location
NCT02760849
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
NA
Active, not recruiting
374 participants
Started: May 2, 2016 · Completed: May 31, 2041
14 conditions
2 sponsors
9 locations
NCT05664282
Orthodontic Treatment in Adolescents With Crowding and Displaced Teeth
NA
Active, not recruiting
131 participants
Started: May 1, 2016 · Completed: Dec 31, 2027
2 conditions
1 sponsor
0 locations
NCT02681328
Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
N/A
Active, not recruiting
328 participants
Started: May 1, 2016 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT03113513
Comparison of Two Apical Repair Methods in Women Undergoing Repairs for Prolapse
NA
Active, not recruiting
312 participants
Started: May 1, 2016 · Completed: Apr 30, 2025
4 conditions
1 sponsor
1 location
NCT03535155
Ultrasound Identification Automation Study
N/A
Active, not recruiting
100 participants
Started: May 1, 2016 · Completed: Dec 31, 2026
1 condition
2 sponsors
0 locations
NCT03077269
Understanding Coagulation and Inflammation in Burns
N/A
Active, not recruiting
250 participants
Started: May 1, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02754037
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
N/A
Active, not recruiting
120 participants
Started: Apr 30, 2016 · Completed: Jun 30, 2025
2 conditions
2 sponsors
1 location
NCT02738398
FDG PET/CT in Lung Cancer Staging
NA
Active, not recruiting
30 participants
Started: Apr 30, 2016 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02594072
Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)
NA
Active, not recruiting
80 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2024
1 condition
2 sponsors
2 locations
NCT02989935
RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD
PHASE4
Active, not recruiting
30 participants
Started: Apr 30, 2016 · Completed: Jul 1, 2026
1 condition
1 sponsor
1 location
NCT02664545
Bridge-Enhanced ACL Repair vs ACL Reconstruction
NA
Active, not recruiting
100 participants
Started: Apr 30, 2016 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT02803905
Islet Transplant Alone in OMENtum
PHASE2
Active, not recruiting
12 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT03134716
Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis
N/A
Active, not recruiting
35 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT02426502
Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
NA
Active, not recruiting
76 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2024
1 condition
2 sponsors
3 locations
NCT02936219
The PREWEAN Study. Weaning of Preterm Infants During the First Year of Life.
N/A
Active, not recruiting
218 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2026
5 conditions
3 sponsors
1 location
NCT02711709
Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care and Induced Frailty
N/A
Active, not recruiting
53 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT02725463
Multichannel Vestibular Implant Early Feasibility Study
NA
Active, not recruiting
30 participants
Started: Apr 30, 2016 · Completed: Mar 31, 2026
6 conditions
3 sponsors
1 location
NCT02743507
The Impact of Bundled Payments on Quality and Cost of Care
N/A
Active, not recruiting
440 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2027
3 conditions
1 sponsor
0 locations
NCT02857933
Daily and Weekly Rehabilitation Delivery for Young Children With Gross Motor Delays
NA
Active, not recruiting
75 participants
Started: Apr 30, 2016 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT02632344
Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients
PHASE2
Active, not recruiting
21 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT02755441
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF
N/A
Active, not recruiting
450 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2028
1 condition
3 sponsors
2 locations
NCT02750319
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
PHASE3
Active, not recruiting
184 participants
Started: Apr 30, 2016 · Completed: Apr 30, 2026
2 conditions
4 sponsors
9 locations
NCT02726711
Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
PHASE1
Active, not recruiting
2 participants
Started: Apr 30, 2016 · Completed: Nov 30, 2025
3 conditions
1 sponsor
1 location
NCT02851862
A Natural History of Late Onset Tay-Sachs Disease
N/A
Active, not recruiting
10 participants
Started: Apr 30, 2016 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT02729350
The Feasibility of the PAINReportIt Guided Relaxation Intervention-INPATIENT
NA
Active, not recruiting
46 participants
Started: Apr 30, 2016 · Completed: Mar 31, 2026
3 conditions
1 sponsor
1 location
NCT05155397
The Dortmund Vital Study: Impact of Biological and Lifestyle Factors on Cognitive Performace and Work Ability
N/A
Active, not recruiting
627 participants
Started: Apr 30, 2016 · Completed: Dec 31, 2037
1 condition
1 sponsor
1 location
Previous
1
More pages
378
379
380
381
382
383
384
More pages
431
Next